OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OXIQUIM$12503.0057

Oxiquim SA

Diversified ChemicalsVerified

Oxiquim's capital structure is supported by a market cap of $311.16 billion and a price-to-book ratio of 2.54, indicating a premium valuation relative to its book value. The company maintains a debt-to-equity ratio of 0.5, suggesting a balanced capital structure, though its net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The current ratio of 1.28 indicates moderate short-term liquidity, with current assets slightly exceeding current liabilities. Profitability metrics show a return on equity (ROE) of 21.33% and a return on assets (ROA) of 11.57%, both outperforming the typical industry benchmarks for diversified chemicals. The company's operating margin of 12.8% (calculated from operating income of $30.31 billion on revenue of $236.76 billion) reflects strong operational efficiency. Gross profit of $74.92 billion on revenue of $236.76 billion indicates a healthy gross margin of 31.6%, which is a key strength in the chemicals sector. Oxiquim's revenue is split between its Commercial and Services segments, with the Commercial segment likely dominating due to the nature of chemical manufacturing and distribution. The Services segment, which includes marine logistics and terminal operations, may provide geographic diversification, though the company's primary operations are concentrated in Chile. No specific geographic revenue breakdown is provided in the input data. The company's growth trajectory is supported by a strong operating cash flow of $36.43 billion and a free cash flow of $2.50 billion, which provides flexibility for reinvestment or shareholder returns. However, capital expenditures of -$13.48 billion suggest a net outflow from investing activities, potentially indicating ongoing infrastructure or expansion projects. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's strong cash flow generation supports a positive growth outlook. Risk factors include a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's financial structure and cash flow generation mitigate near-term dilution pressures. Recent events, such as filings and transcripts, are not detailed in the input data, but the company's financial performance and capital structure suggest a stable and well-managed business. The absence of specific recent events does not detract from the company's overall financial health.

30-day price · OXIQUIM+150.56 (+1.2%)
Low$11874.46High$12850.00Close$12500.00As of15 May, 00:00 UTC
Profile
CompanyOxiquim SA
TickerOXIQUIM.SN
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Oxiquim SA is a Chile-based diversified chemicals company that develops, manufactures, and distributes formaldehyde-based resins, adhesives, and wood coatings through its Commercial segment, while providing marine logistics and terminal operations through its Services segment.

Classification. Oxiquim is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

Oxiquim's capital structure is supported by a market cap of $311.16 billion and a price-to-book ratio of 2.54, indicating a premium valuation relative to its book value. The company maintains a debt-to-equity ratio of 0.5, suggesting a balanced capital structure, though its net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The current ratio of 1.28 indicates moderate short-term liquidity, with current assets slightly exceeding current liabilities. Profitability metrics show a return on equity (ROE) of 21.33% and a return on assets (ROA) of 11.57%, both outperforming the typical industry benchmarks for diversified chemicals. The company's operating margin of 12.8% (calculated from operating income of $30.31 billion on revenue of $236.76 billion) reflects strong operational efficiency. Gross profit of $74.92 billion on revenue of $236.76 billion indicates a healthy gross margin of 31.6%, which is a key strength in the chemicals sector. Oxiquim's revenue is split between its Commercial and Services segments, with the Commercial segment likely dominating due to the nature of chemical manufacturing and distribution. The Services segment, which includes marine logistics and terminal operations, may provide geographic diversification, though the company's primary operations are concentrated in Chile. No specific geographic revenue breakdown is provided in the input data. The company's growth trajectory is supported by a strong operating cash flow of $36.43 billion and a free cash flow of $2.50 billion, which provides flexibility for reinvestment or shareholder returns. However, capital expenditures of -$13.48 billion suggest a net outflow from investing activities, potentially indicating ongoing infrastructure or expansion projects. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's strong cash flow generation supports a positive growth outlook. Risk factors include a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's financial structure and cash flow generation mitigate near-term dilution pressures. Recent events, such as filings and transcripts, are not detailed in the input data, but the company's financial performance and capital structure suggest a stable and well-managed business. The absence of specific recent events does not detract from the company's overall financial health.
Key takeaways
  • Oxiquim maintains a balanced capital structure with a debt-to-equity ratio of 0.5 and a market cap of $311.16 billion.
  • The company's profitability is strong, with a return on equity of 21.33% and a return on assets of 11.57%.
  • Oxiquim's Commercial segment is a key driver of revenue, supported by a healthy gross margin of 31.6%.
  • The company's liquidity is moderate, with a current ratio of 1.28 and a negative net cash position after subtracting total debt.
  • Oxiquim's free cash flow of $2.50 billion provides flexibility for reinvestment or shareholder returns.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's strong gross margin of 31.6% and operating margin of 12.8% suggest a positive margin outlook driven by efficient operations.
  • **rd_outlook_rationale**: No specific R&D data is provided, but the company's focus on chemical development implies ongoing R&D investment.
Financial snapshot
PeriodHA-latest
CurrencyCLP
Revenue$236.76B
Gross profit$74.92B
Operating income$30.31B
Net income$26.09B
R&D
SG&A
D&A
SBC
Operating cash flow$36.43B
CapEx-$13.48B
Free cash flow$2.50B
Total assets$225.47B
Total liabilities$103.17B
Total equity$122.29B
Cash & equivalents$7.03B
Long-term debt$60.80B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$12503.00
Market cap$311.16B
Enterprise value$364.92B
P/E11.9
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income12.0
EV/OCF10.0
P/B2.5
P/Tangible book2.5
Tangible book$122.29B
Net cash-$53.76B
Current ratio1.3
Debt/Equity0.5
ROA11.6%
ROE21.3%
Cash conversion1.4%
CapEx/Revenue-5.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricOXIQUIMActivity
Op margin12.8%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin11.0%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin31.6%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-5.7%-7.1% medp25 -12.7% · p75 -4.4%above median
Debt / equity50.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 09:34 UTC#01f73b13
Market quoteclose CLP 12503.00 · shares 0.02B diluted
no public URL
2026-05-04 11:46 UTC#c3cd7724
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 11:47 UTCJob: 886a344a